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LIABILITY FOR SERUM HEPATITIS IN BLOOD TRANSFUSIONS
I. INTRODUCTION
In the past legal recovery has been uniformly denied for blood and
plasma' transfusions causing homologous serum hepatitis2 Two recent
state supreme court decisions have departed from this previous trend. In
Cunningham v. MacNeal Memorial Hospital' the Supreme Court of Illi-
nois held that it may be possible to recover under a theory of strict liabil-
ity in tort and the Supreme Court of Pennsylvania in Hoffman v. Miseri-
cordia Hospital of Philadelphia4 held that a nonsale common law warranty
is a valid theory of recovery.
Hepatitis is an inflamation of the liver. Homologous serum hepatitis
is an inflamation of the liver due to a virus. This virus can enter the body
only through the blood; a hospital patient acquires the disease primarily
through transfusion. The incubation period of the disease is extremely
long varying from fifty to one hundred-eighty days. A carrier shows no
visible signs of the disease during this incubation period and can transmit
the disease to others by becoming a blood donor.5 It is claimed that there
is no means of detecting the virus in a donor, although this has been a
topic of dispute in recent years.' Various techniques have been developed
to treat plasma in order to destroy any virus present.7
With the advent of disposable needles and stricter sterilization prac-
tices the risk of contracting homologous serum hepatitis has been reduced.
The most reliable studies put the current attack rate at two percent of
those patients transfused. The resultant illness may be mild, moderate or
1 For our purposes we can consider blood to be composed of liquid and cells. Plasma is
the liquid portion of the blood. It is the blood without blood cells. Plasma should be distin-
guished from serum which is plasma without the dotting material. DORLAND'S MEDICAL
DICTIONARY 1168 (24th ed. 1965).
2 Homologous serum hepatitis is also called homologous serum jaundice or serum hepatitis.
Homologous serum hepatitis should be distinguished from infectious hepatitis which is not
transmitted through the blood.
There are other injuries possible from blood transfusions. The most common of which is
incompatible blood due to mismatched blood groups. Diseases other than homologous serum
hepatitis which are transmitted by transfusion are malaria and syphilis. See generally 42
MINN. L.R. 640-661 (1958).
8.- Ill. - , 266 N.B.2d 897 (1970).
4 439 Pa. 501, 267 A.2d 867 (1970).
5 A high prevalence of serum hepatitis among drug addicts has been shown. This is prob-
ably due to the use of unsterilized needles. Many addicts sell their blood to blood banks and
hospitals thereby transmitting the disease to the patient. The possibility of more careful screen-
ing of blood donors will be discussed later. 2 GRAY, ATroRNBY's TEXTBOOK OF MEDICINE
5 38.34 (3d ed. 1970).
0 48 Cm. BAR REC. 204 (1967) and 49 Cl. BAR REc. 22 (1967).
7 Allen, Enerson, Barron and Sykes, Pooled Plasma with Little or No Risk of Homologopa
Serum Jaundice, 154 A.M.A.J. 103 (1954), found that plasma stored at higher than room
temperature (32°C) for six months kills any serum hepatitis virus present.
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severe. Victims of this disease require six to eight weeks of hospitaliza-
tion;" the disease may be fatal.9
The setting in which litigation in this area arises has a common factual
pattern. The patient is advised by his doctor that a blood transfusion is
necessary. The patient is usually not in a position to question the doctor's
advice or to select a donor. Blood is then prescribed by the doctor but
billed separately to the patient. The hospital has received the blood from
a blood bank which has in turn received the blood from voluntary or paid
donors who were not thoroughly examined before the blood was given.
The patient then receives the blood contaminated by the virus. The
disease usually manifests itself well after the patient has left the hospital.
The patient is understandably angry. He entered the hospital to get well,
not contract additional diseases.'
Victims of serum hepatitis have attempted recovery under three the-
ories: negligence, breach of warranty, and strict liability in tort.
II. THEORIES OF RECOVERY
A. Negligence
Two early cases involving negligence arose from the distribution of
dried pooled plasma that was used during World War II. At the end of
the War the Red Cross gave the surplus stock to the states for distribution
to hospitals and blood banks. At that time the incidence of homologous
serum hepatitis from pooled plasma was much higher than from whole
blood."
In Parker v. State,12 the first reported homologous serum hepatitis case,
a patient being treated for shock was given dried pooled plasma distributed
by the state to the hospital. Although he recovered from his injury, he
died two months later from hepatitis. His widow brought an action
against the state daiming that the state should have warned the doctor of
the danger of hepatitis. The court affirmed a dismissal of the complaint
8 2 GRAY, supra note 5, at 538.35 and 538.36.
9 Fatalities run about 2% of those contracting the disease. Id. 38.37.
10 NoRDSTRoM AND LATTriN, LAW OF SALES § 80 (1970).
11Dried pooled plasma is a substitute for whole blood. Whole blood of 10-50 donor's is
converted into dried powder and "pooled" into one container. When water is added the
plasma may be transfused to the patient. Pooled plasma has advantages over whole blood in
that it is more stable and there is no need to type the recipient (patient). Thus it is extremely
useful in an emergency situation. However, if the blood of only one of the 10-50 donor's is
infected, it will infect the whole container therefore the risks of hepatitis are much greater. In
1952 the risk of hepatitis from pooled plasma was 12% as compared to 2% for whole blood.
See generally A Report of the Committee on Medicolegal Problems of the American fedical
Ass'n., Mfedicolegal Aspects of Blood Transfusion, 151 A.M.AJ. 1435 (1952). Plasma storage
techniques have reversed the situation so that today plasma may be made safer than whole
blood. Supra, note 7.
12280 App. Div. 157, 112 N.Y.S.2d 695, motion for leave to appeal denied, 304 N.Y.
989, 109 N.E.2d 474 (1952).
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on the ground that the state had a right to assume that a doctor using
the plasma would know of the danger and use it only in limited situations
such as emergencies. Although the doctor was not a party to the action
the court indicated that he would not have been found negligent since
there had been a need for a fast transfusion and the time required to wait
for the proper preparation of whole blood had been outweighed by the
need for immediate treatment for shock.
Hidy v. State13 was a similar case, but in it the decedent had been in
the hospital for many hours prior to an operation and there was time to ob-
tain the safer whole blood. The court again held that the State was not
liable. It noted that the causal link between the state and the patient was
interrupted by the doctor. It was therefore the doctor who really directed
the plasma to the patient and not the state. The court then indicated that
there may have been negligence on the part of the doctor in using plasma
instead of the then safer whole blood, especially in the absence of an emer-
gency.
Negligence per se as a basis of liability was attempted in Merck and
Company v. Kidd.'4 There the plaintiff argued that supplying blood con-
taining homologous serum hepatitis virus violated the Tennessee Food,
Drug and Cosmetic Act.15 The statute stated that a drug is adulterated if
it contains any "filthy" substance and that such adulterated drugs are pro-
hibited. The plaintiff contended that the virus in the plasma was "filthy,"
thereby making the plasma adulterated. The court, speaking through Judge
Potter Stewart, held that since the presence of the virus could not be de-
tected or destroyed, 16 the virus was not "filthy" within the "intendment" of
the statute.17  The dissenting judges argued that in other cases food con-
tamination by bacilli was considered "filthy" for purposes of the Tennessee
Food, Drug and Cosmetic Act." They reasoned that the hepatitis virus is a
disease producing substance like food bacilli and should be treated the
same. The dissenting judges said that detectability of the virus was ir-
relevant to the question of whether the substance was "filthy." The negli-
gence theory cases after Merck involved suits against nonprofit hospitals
and blood banks. Some of these suits encountered the defense of charit-
able immunity."9
13207 Misc. 207, 137 N.Y.S.2d 334 (N.Y. Ct CL. 1955) aft'd, 3 N.Y. 2d 756, 143 N.E2d
528 (1957).
14 242 F.2d 592 (6th Cir. 1957)
1G TENN. CODE ANN. § 52-103,52-115 (1955).
16This was a misassumption on the part of Judge Stewart since storing plasma at 32"C
for six months will destroy the virus. Supra note 7.
17 242 F.2d 592 (6th Cir. 1957).
18 Citing Kenower v. Statler Hotels Co., 124 F.2d 658 (6th Cir. 1942), and United States
v. Sprague, 208 F. 419 (E.D.N.Y. 1913).
10 Gile v. Kennewick Public Hospital District, 48 Wash. 2d 774, 296 P.2d 662 (1956), al-
though involving mismatched and not virus contaminated blood, presents many of the same is-
.1971
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Another negligence issue centered on the duty of the hospital to warn
the patient of the danger of hepatitis. In Fischer v. Wilmington General
Hospital20 the plaintiff contended that since the risk of hepatitis was known
to the hospital there was a duty to warn the patient. Chancellor Seitz
in dismissing the complaint held that, since the risk of hepatitis was low
compared to the risk of excessive blood loss and as there was a general prac-
tice in the medical profession not to advise patients of the risk of hepatitis,
the hospital had no duty to warn the patient and therefore had not been
negligent.
The later cases, consistent with these earlier examples, have denied any
recovery for negligence. The best a plaintiff has accomplished under a
theory of negligence is to avoid a summary judgment on appeal and allow
the case to be remanded.21  Usually this is a Pyrrhic victory since the judge,
although complying with the procedural necessity to remand due to an in-
sufficient record, usually expresses doubt as to any negligence on the part
of the hospital2 Thus negligence has been extremely difficult to prove
in serum hepatitis cases. There is no legal duty to warn of the danger and
since there has been no way until recently to detect the virus in the donor's
blood, if the hospital has used due care in storing and processing the blood
it has not been held liable. However, if the hospital has not used proper
preventive techniques such as the careful screening of donors,28 it may be
liable for lack of due care. There is no reported litigation on this issue.
Having no success with the negligence theory the plaintiffs' bar proceeded
to breach of warranty theories, where negligence need not be proven. But
this too presented some problems.
B. Breach of Warranty
Various types of warranty theories have been attempted. These include
the implied warranties of merchantability and fitness for purpose, express
warranty and, most recently, nonsale common law implied warranties. Be-
fore the adoption of the Uniform Commercial Code, most suits for breach
of warranty were pursued under section 15 of the Uniform Sales Act.24
sues as the serum hepatitis cases. This case is instructive to show the resourcefulness of the
plaintiff's lawyers to avoid a charitable immunity statute.
20 51 Del. 554, 149 A.2d 749 (1959).
21 Jackson v. Muhlenberg Hospital, 96 N.J.S. 314, 232 A.2d 879 (Law Div. 1967), rev'd, 53
N.J. 138, 249 A.2d 65 (1969) (record too meagre); Sloneker v. St Joseph Hospital, 233 F. Supp.
105 (D. Colo. 1964).
22 Id.
23 Since there is no completely reliable test for the presence of virus in the donor's blood
prevention may be accomplished by screening donor's primarily in the form of obtaining a
medical history. This is unreliable since the donor may lie, as in the case of an addict, or may
not be aware that he may be a carrier of the virus because he has forgotten he has had a previous
transfusion. Supra note 5. But there is still a basis for liability since some hospitals are more
careful in screening donor's and therefore have a lower incidence of hepatitis.
2 4 UNIFORM SALEs Ac'r § 15 (1906).
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This section corresponds to sections 2-314 and 2-315 of the Uniform Com-
mercial Code.25
The landmark case in this area is Perlmutter v. Beth David Hospital.21
The plaintiff had attempted to frame a warranty cause of action by con-
tending that there was the requisite sale of blood since she was separately
billed for sixty dollars. She further contended that the defendant knew
the purpose for which the blood was to be used and that she relied on the
hospital's skill and judgment in selecting the blood. Since the blood con-
tained a disease producing virus it was not "fit," thereby giving rise to a
breach of the implied warranties of merchantability and fitness for parti
ular purpose. The case was decided solely on whether supplying the blood
for transfusion was a sale. The New York Court of Appeals in a four to
three decision enunciated the rule which was to influence courts in many
jurisdictions. The court held that implied warranties applied only to
sales transactions. The supplying of blood, although separately billed to
the patient, was not a sale but part of the service contract between the
patient and the hospital; therefore no implied warranties were made. In
reaching this decision the court employed a doctrine described as the "pre-
dominant feature" or "essence" test used in pre-code food cases. Under
this test the court looked at the overall transaction between the hospital
and the patient and decided whether that transaction was predominantly
a contract for services or a sale. It did not consider the transaction as
divisible, part into services, part into sale. The court summarized its de-
cision as follows:
The supplying of blood by the hospital was entirely subordinate to its
paramount function of furnishing trained personnel and specialized facil-
ities in an endeavor to restore plaintiff's health. It was not for blood-
2 5 The pertinent parts of these sections reads as follows:
Section 2-314. Implied Warranty: Merchantability; Usage of Trade.
(1) Unless excluded or modified (Section 2-316), a warranty that the goods
shall be merchantable is implied in a contract for their sale if the seller is a merchant
with respect to goods of that kind. Under this section the serving for value of food
or drink to be consumed either on the premises or elsewhere is a sale.
(2) Goods to be merchantable must be at least such as
(a) pass without objection in the trade under the contract description; and
(c) are fit for the ordinary purposes for which such goods are used....
The only difference between this section and section 15 of the UNIFoRM SALEs AcT
is the inclusion here of the sentence clarifying that serving food for value is a sale
and not a service. Therefore it is within this section. But this change is highly sig-
nificant because it expresses the liberalized policy of remedies under the UNIFORM
COMMifERCE CODE.
Section 2-315. Implied Warranty: Fitness for Particular Purpose.
Where the seller at the time of the contracting has reason to know any particular
purpose for which the goods are required and that the buyer is relying on the seller's
skill or judgment to select or furnish suitable goods, there is unless excluded or modi-
fied under the next section an implied warranty that the goods shall be fit for such
purpose.
26 308 N.Y. 100, 123 NB.2d 792 (1954).
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or iodine or bandages-for which plaintiff bargained, but the where-
withal of the hospital staff and the availability of hospital facilities to pro-
vide whatever medical treatment was considered advisable. The conclu-
sion is evident that the furnishing of blood was only an incidental and
very secondary adjunct to the services performed by the hospital and, there-
fore, was not within the provisions of the Sales Act.27
New York courts had previously held that supplying food in a res-
taurant was a sale and not a service. The Perlmutter majority distin-
guished these food cases from the present case by reasoning that one goes
to restaurants to buy food, not services, but one goes to a hospital for the
service of a cure, not for blood or bandages. The court emphasized the
fact that hepatitis contaminated blood could not be detected; therefore,
there was no negligence involved in this injury. It refused to hold the
hospital liable by warranty under such circumstances, stating that to do
so would make hospitals virtual insurers.
The dissent, written by Judge Froessel, retorted that the plaintiff was not
suing for negligent services but for bad blood, for which she had been
separately billed. The dissent asserted that the plaintiff should be given a
chance to prove the claim of a sale, since by the definition of "sale" under
the Uniform Sales Act this was arguably a sale.28 Judge Froessel saw no
distinction between the food cases and the present case.
The majority in Perlmutter, by emphasizing the service aspect instead
of the separate billing sale aspect of this case, had made a decision which
protected hospitals from liability. As the close division of the court indi-
cates, it could as easily have emphasized the sale aspect, thereby making a
decision to protect the patient. Having a major policy decision turn on the
sale-service distinction has been extensively criticized.29 But the distinction,
had established a pattern which was readily accepted. 0 The Perlmutter
rule was reinforced by many legislatures. Statutes were passed in many
27 Id. at 106, N..2d at 795.
28 UNiIORm SALES Acr § 1(2):
A sale of goods is an agreement whereby the seller transfers the property in goods
to the buyer for a consideration called a price.
2D 103 U. PA. L. REv. 833 (1955); 69 HARV. L. REV. 391 (1955); Farnsworth, Implied
Warranties in Non-Sales Cases, 57 CoLuM. L. REv. 653 (1957); 42 MMNN. L. REV. 640 (1958);
29 ST. JoHN's L REV. 305 (1955); 37 NOTRE DAM I.LAwYR 565 (1962); 33 Iss. LJ.
253 (1962); 48 Ci. BAR REc. (1967). See also Russell v. Community Blood Bank, Inc., 185
So. 2d 749, 752 (Fla. Cr. App. 1966) where the criticism of the Perlmutter sales-service distinc-
tion receives judicial recognition: "It seems to us a distortion to take what is a least arguably, a
sale, twist it into the shape of a service, and then employ this transformed material in erecting a
major policy decision."
30 Sloneker v. St. Joseph Hospital, 233 F. Supp. 105 (D. Colo. 1964) ;White v. Sarasota
County Pub. Hosp. Bd., 206 So.2d 19 (Fla. Ct App. 1968); Lovett v. Emory University,
Inc., 116 Ga. App. 277, 156 S.E.2d 923 (1957); Koenig v. Milwaukee Blood Ctr. Inc., 23 Wis.
2d 324, 12 N.W.2d 50 (1964).
Similar reasoning is present in mismatched blood cases: Diblee v. Dr. W. H. Groves Latter
Day Saints Hospital, 12 Utah 2d 241, 364 P.2d 1085 (1961); Gile v. Kennewick Public Hospi-
tal District, 48 Wash. 2d 774, 296 P. 2d 662 (1956), and cases collected in Annot., 59 A.L.R.2d
761 (1958).
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states stating that the supplying of blood by a hospital or blood bank was
not a sale for purposes of warranty protection.31
In the 1960's there was a gradual erosion of the Perlmutter rule.
Joining academic criticism, some courts began questioning the rule.'
Whatever logic the Perlmutter rule had concerning hospitals such logic
is less compelling where blood banks, particularly commercial blood banks,
are being sued. Blood banks supply no predominate service but rather
only blood while charging the patient. This is more arguably a sale. So,
some jurisdictions distinguished hospitals from blood banks33 while other
jurisdictions followed the Perlmutter rule.14
Some courts limited the Perlmutter rule to implied warranties and held
that a complaint against a hospital or blood bank was sufficient if it stated a
cause of action in express warranty.r'
31 ARUZ. REV. STAT. ANN. § 36-1151 (West Supp. 1971); CAL. HEALTH AND SAFFY
CODE § 1623 (West 1955); DEL. CODE .ANN. tit. 5A § 2-316(5) (Spec. U.C.C. Pamphlet
1971); MASS. GEN. LAWS ANN. ch. 106, § 2-316(5) (Michie Supp. 1970); MIcI. COMP.
LAws ANN. § 691-1511 (West Supp. 1971); MISS. CODE ANN. § 7129-71 (Harrison Supp.
1968); NEB. REV. STAT. § 71-4011 (R.S. Supp. 1969); N.M. STAT. ANN. § 12-12-5 (Smith
Supp. 1971); N.D. CENT. CODE § 41-02-33(3) (d) (Smith Supp. 1971); OHIo REV. CODE
ANN. § 2108-11 (Page Supp. 1971); OKLA. STAT. ANN. tit. 63 § 2151 (West Supp. 1971);
S.C. CODE ANN'. § 32-559 (Michie Supp. 1970), S.D. CODE § 57-4-33.1 (Smith Supp. 1971);
Wisc. STAT. ANN. 146-31 (West Supp. 1971).
Most of these states incorporated provisions protecting hospitals from liability as an amend-
ment to the warranty section in the state UNIFOnf CONMERCIAL CODE. Ohio incorporated a
similar provision in the Uniform Anatomical Gift Act which reads as follows:
"§ 2108.11 Transaction involving human tissue not a sale.
The procuring, furnishing, donating, processing, distributing, or using human
whole blood, plasma, blood products, blood derivatives, and products, corneas, bones,
organs, or other human tissue except hair, for the purpose of injecting, transfusing,
or transplanting any of them in the human body, is declared for all purposes to be the
rendition of a service by every person, firm, or corporation participating therein,
whether or not any remuneration is paid therefor, is declared not to be a sale of any
such items, and no warranties of any kind or description are applicable thereto.
It should be noted that recovery under a theory of strict liability is theoretically not prohibited
by these statutes.
32 Gottsdanker v. Cutter Laboratories, 182 Cal. App. 2d 602, 6 Cal. Rptr. 320 (App. Ct.
1966) involved a suit on implied warranty for injury due to polio vaccine. The defendant
manufacturer contended that since the California legislature had ruled that the supplying blood
into the body was a service then supply of the drug by analogy (since the drug was partly ob-
tained from horse blood) was also a service. The court rejected this contention and questioned
the logic underlying Perlmutter.
3 3 Hoder v. Sayet, 196 So. 2d 205 (Fla. Ct. App. 1967); Russell v. Community Blood Bank,
Inc., 185 So. 2d 749 (Fla. Ct. App. 1966) modified, 196 So. 2d 115 (Fla. 1967). In the same
state supplying of blood by a hospital was not a sale. White v. Sarasota County Public Hospital
Board 206 So. 2d 19 (Fla. Ct. App. 1968). See also Carter v. Interfaith Hospital of Queens, 60
Misc. 2d 733, 304 N.Y.S. 2d 97 (1969) where even in New York the possibility of distinguish-
ing blood banks from hospitals in the sale-service distinction is entertained. This is reminisent
of the distinctions developed in the pre-Code food cases.
34 Whitehurst v. American National Red Cross, 1 Ariz. App. 326,402 P.2d 584 (1965); Balk-
owitsch v. Minneapolis War Memorial Blood Bank, 270 Minn. 151, 132 N.W.2d 805 (1965);
Goelz v. J. K and Susie L. Wadley Research Institute and Blood Bank, 350 S.W.2d 573 (Tex.
Civ. App. 1961).
35 Jackson v. Muhlenberg Hospital 96 N.J. Super. 314, 232 A.2d 879, rev'd per curiam,
53 N.J. 138, 249 A.2d 65 (1968) (record too meagre); Napoli v. St. Peter's Hospital of Brooklyn
19711 NOTES
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The sales-service distinction of Perlmutter was further eroded in the
1960's by the acceptance of the Uniform Commercial Code. The specific
inclusion of food as a sale for warranty purposes"' demonstrated an area in
which some courts had considered as a nonwarranty service. The liberal
administration of remedies to aggrieved parties as a stated policy of the
Uniform Commercial Code also influenced the courts considerably.3 7
Moreover, the general legal trend of expanding causes of action further
eroded the Perlmutter decision. As the Code gained acceptance, protection
was extended to nonsale service transactions in areas other than blood
cases.3
Finally, in Jackson v. Muhlenberg Hospital a New Jersey court rejected
the Perlmutter rule holding that transfusion of whole blood for a charge
was not a sale.39
Then in 1970, the Supreme Court of Pennsylvania considered the prob-
lem in Hoffman v. Misericordia Hospital of Philadelphia.4° It is note-
worthy that in 1953 Pennsylvania became the first state to enact the Uni-
form Commercial Code. Thus Pennsylvania has had the longest experi-
ence with the mechanics and philosophy of the Code. The court noted
that the Perlmutter case hadn't considered the possibility of warranties in
nonsale cases thereby placing the emphasis on whether or not the elements
of a sale were present.4 ' Judge Cagen speaking for the court noted that
Pennsylvania had nonsale warranties before the enactment of the Uni-
form Commercial Code and, citing Comment 2 § 2-313 of the Code,'
said that the enactment of the Code was not intended to impede progress
of implied warranties in nonsale situations. The court, in overruling the
defendant's demurrer stated:
213 N.Y.S.2d 6, 174 N.E. 2d 923 (N.Y. Sup. Ct. 1961) may have been overruled sub silento
in Payton v. Brooklyn Hospital 19 N.Y. 2d 610, 234 N.E. 2d 891 (1967).
36 Supra note 25.
3 7 UNIFORM COMMBRcAI. CODE § 1-106 and § 2-313, Comment 2.
38 Cintrone v. Hertz Truck Leasing, 45 N.J. 434, 212 A.2d 769 (1965); Newmark v. Gim-
bet's Inc. 102 N.J. Super. 279, 246 A.2d 11 (1968).
39 232 A.2d 879 (Law Div. 1967), rev'd, 53 N.J. 138, 249 A.2d 65 (1969) (record too
meagre).
40 439 Pa. 501, 267 A.2d 867 (1970).
41 The possibility of liability under a theory of non-sale warranty in serum hepatitis cases
was suggested as early as 1955 in 69 HARV. L REV. 305 (1955).
4 2 UNIFORM COMM RcAUL Cor)B § 2-313 Comment 2:
Although this section is limited in its scope and direct purpose to warranties made
by the seller to the buyer as part of a contract for sale, the warranty sections of this
Article are not designed in any way to disturb those lines of case law growth which
have recognized that warranties need not be confined either to sales contracts or to the
direct parties to such a contract. They may arise in other appropriate circumstances
such as in the case of bailments for hire, whether such bailment is itself the main con-
tract or is merely a supplying of containers under a contract for the sale of their con-
tents. The provisions of Section 2-318 on the third party benificiaries expressly rec-
ognize this case law development within one particular area. Beyond that, the matter
is left to the case law with the intention that the policies of this Act may offer useful
guidance in dealing with further cases as they may arise.
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In view of our case law implying warranties in nonsales transactions,
it cannot be said with certainty that no recovery is permissible upon the
daim here made, even if it should ultimately be determined that the trans-
fer of blood from a hospital for transfusion into a patient is a service....43
The court only decided that recovery did not hinge on whether the trans-
fer of blood was a sale or a service. It carefully limited its decision by
making explicit the issues not decided by the court: (1) the extent which
implied warranties in nonsale situations should be given effect, (2) the duty
of the hospital to warn the patient, (3) whether charitable immunity should
extend to the contractual warranties involved here,44 (4) any defenses for
breach of warranty such as assumption of risk or a break in the chain of
proximate cause. By so limiting its decision the court refused to make the
policy decision of Perlmutter to protect hospitals until it had further facts.
Contemporaneous with the Hoffman case, lawyers were constructing
other theories to challenge the Perlmutter rule, one of which was strict
liability.
C. Strict Liability45
Strict liability in tort incorporates the concept of strict liability em-
bodied in warranty theories without the accretion of defenses which have
attached to warranties. 46
The most quoted statement of strict liability in tort is found in the
Restatement (Second) of Torts § 402 A which reads as follows:
(1) One who sells any product in a defective condition unreasonably
dangerous to the user or consumer or to his property is subject to liability
for physical harm thereby caused to the ultimate user or consumer, or to
his property, if
(a) the seller is engaged in the business of selling such a product, and
(b) it is expected to and does reach the user or consumer without sub-
stantial change in the condition in which it is sold.
(2) The rule stated in Subsection (1) applies although
(a) the seller has exercised all possible care in the preparation and sale
of his product, and
(b) the user or consumer has not bought the product from or entered
into any contractual relation with the seller.47
The essential element needed to be shown under this theory is that
the product was "in a defective condition unreasonably dangerous." The
underlying policy of strict liability in tort is risk distribution. Therefore,
43 439 Pa. at -, 267 A.2d at 870.
4 4 Pennsylvania had abolished charitable immunity as to negligence in Nolan v. Tifereth
Israel Synagogue, 425 Pa. 106, 227 A.2d 675 (1967).
4 5 See generally Boland, Strict Liability in Tort for Transfusing Contaminated Blood, 23
ARK. L. RM. 236 (1969).
4 0 RSTATmENT OF ToRTs (SEcoND) § 402 A, comment m (1966).
471d.
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liability is placed on the party that can best anticipate and bear the loss.
The party bearing the risk can insure and spread the loss among the users
of the product by raising his prices.
Under a theory of strict liability in tort, it was argued that hospital or
blood banks are better candidates to spread the loss through high prices
for blood. But, courts initially denied recovery on this basis. In Balko-
witsch v. Minneapolis War Memorial Blood Bank, Inc.,48 the court simply
refused to consider the concept of strict liability but decided the protection
of hospitals from liability was of higher policy consideration:
We find it difficult to give literal application of principles of law designed
to impose strict accountability in commercial transactions to a voluntary and
charitable activity which serves a humane and public health purpose.40
The inability to detect the virus is also of concern to some courts. In
Russell v. Community Blood Bank, Inc.,50 the lower court having found a
warranty cause of action held the defendant liable for injuries capable of
being detected. But the Supreme Court of Florida citing § 402A said
this was contrary to the court's decision in Green v. American Tobacco Co."
which held that a manufacturer was strictly liable for breach of warranty
even if the danger was not detectable.
Recovery under theory of strict liability in tort was denied in Jackson
v. Muhlenberg Hospital.2  The court held that the strict liability theory in
the blood cases was defeated by the unavoidably unsafe exception of §
402A as enunciated in comment (k):
There are some products which, in the present state of human knowledge,
are quite incapable of being made safe for their intended or ordinary use.
These are especially common in the field of drugs.53
Rabies vaccine is cited as one example of an unavoidably unsafe prod-
uct. The reactions to rabies vaccine are dangerous, but use of the vaccine
is justified in view of the alternatives.
The defenses of nondetectibility and the comment (k) exception, along
with the policy considerations were recently considered in Cunningham v.
MacNeil Memorial Hospital.54 Here, the court noted that the concept of
strict liability in tort had been accepted in Illinois.55 After the plaintiff
attempted to state a cause of action for strict liability by alleging that
blood received was defective and in an unreasonably dangerous condition,
48270 Minn. 151, 132 N.W.2d 805 (1965).
49 Id. at 159, 132 N.W.2d at 811.
50 185 So. 2d 749 (Fla. Ct. App. 1966).
51 154 So. 2d 169 (Fla. 1963).
52 96 N.J. Super. 314,232 A.2d 879 (1967).
53 RESTAT M NT OF TORTS (SEcolND) § 402 A, comment k (1966).
5 -Ill.-, 266 N.E.2d 897 (1970).
55 Suvada v. White Motor Co., 32 Ill. 2d 612, 210 N.E.2d 182 (1965).
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the hospital raised as a preliminary defense that the blood was not a prod-
uct as required under Section 402A since it was not processed. However,
the court cited comment (e) of the Restatement and stated that the blood
need not be processed to be a product.56
The defendant then attempted to use the Perlmutter rule by arguing
that if this transfer of blood was a service then the defendant was not
"engaged in the business of selling blood" as required by Section 402A.
However, the court rejected the Perlmutter rule as "simply unrealistic."
In doing so, Russell and the dissenting opinion of Perlmutter were cited
with approval.
On the detectibility issue the court ruled against the defendant citing
§ 402A (2) (a) supra noting:
To allow a defense to strict liability on the ground that there is no way,
either practical or theoretical, for a defendant to ascertain the existence of
impurities in his product would be to emasculate the doctrine and in a very
real sense would signal a return to a negligence theory.57
The court thereby emphasized the no fault concept of strict liability
noting that the lack of detectibility had no effect in warranty cases and
would not be accepted as a defense in the strict liability area.
Considering the comment (k) exception concerning unavoidably un-
safe products, the court stated that the exception only applied to pure prod-
ucts which, even if properly prepared, involved substantial risk of injury
to the user. This exception does not apply to the contaminated blood situ-
ation in which the product is alleged to be impure. In other words, in the
case of blood there is the requisite "defective" virus, but in the case of a
vaccine such as rabies no such defect is present. Therefore, the rabies vac-
cine is not within the scope of § 402A.
Responding to the policy argument for the protection of hospitals the
court noted:
Defendant implicitly raises the ad terrorem argument that allowing a strict
tort liability theory to obtain in this case will "open the flood gates" to
disastrous litigation which will ultimately thwart the fulfillment of the
hospitals worthy mission by drainage of their funds for purposes other
than those intended. Our answer to this contention is that.., we do not
believe in this present day and age, when the operation of eleemosynary
hospitals constitutes one of the biggest businesses in this country, that hos-
pital immunity can be justified on the protection of the funds theory. The
concept of strict liability in tort logically, and we think, reasonably dictates
that an entity which distributes a defective product for human conception,
56 Comment e reads as follows:
"Normally the rule stated in this Section will be applied to articles which already
have undergone some processing.. . . The rule is not, however, so limited, and the
supplier of poisonous mushrooms which are neither cooked, canned, packaged, nor
otherwise treated is subject to the liability here stated."
57- Ill. - , 266 N.E.2d 902 (1970).
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whether for profit or not, should legally bear the consequences of injury
caused thereby, rather than allowing such loss to fall upon the individual
consumer who is entirely without fault.58
Thereafter, the court held the complaint sufficient and remanded the case to
proceed to trial.
The court in Cunningham made a policy decision as did the court in
Perlmutter. The Perlmutter court decided to protect the hospital from
liability, whereas the Cunningham court decided to protect the patient.
III. THE POLICY CONSIDERATIONS
From the foregoing discussion, it is obvious that the sales-service dis-
tinction of Per/mutter is an insufficient basis for the blood case decisions.
The question of liability involves the weighing of other considerations.
These considerations include the effect of liability on the price of blood, the
possibility of new methods of detection or prevention of serum hepatitis
and the possible alternatives to legal liability such as insurance.
Assuming, for the moment, that the presence of serum hepatitis virus
in the blood is undetectible, then the case for holding hospitals and others
liable on theories of warranty and strict liability in tort is questionable.
The reason is not based entirely on the fact of undetectibility. Undetect-
ibility has not been a bar to imposing liability in warranties or strict liability,
in tort in other areas.59 However, since the hepatitis virus can not be de-
tected, the two percent attack rate of the disease cannot be reduced. The
overall effect of this may be a substantial rise in the price of blood. The
purpose of strict liability is to distribute the cost to the users of the product
so that each bears a small burden of the cost of liability. The question is
whether the two percent attack rate of serum hepatitis is too high to effec-
tuate this purpose. Some figures will demonstrate this point. Approxi-
mately 30,000 patients are bedridden by hepatitis every year. These pa-
tients require up to eight weeks of hospitalization. 0 If hospitals are held
strictly liable, then each of these patients could expect considerable recov-
eries. Recoveries might conservatively average $5,000 in out of pocket ex-
penses (hospital bills, lost wages, etc.) alone. This means the hospital
must insure against one hundred and fifty million dollars (30,000 patients
x $5,000 each) of known risks every year. Insurance companies would
charge hospitals more than one hundred and fifty million dollars in pre-
miums in order to make a profit. The effect on the price of blood would
be considerable. Spreading this cost over the one and a half million
transfusions per year, the price of blood would increase by approximately
58 Id. at - , 266 N.E.2d at 904.
5 9 See Vlases v. Montgomery Ward and Co., 377 F.2d 846 (3d Cir. 1967) (avian leukosis
in chickens); Green v. American Tobacco Co., 154 So. 2d 169 (Fla. 1963), cert. denied, 377
U.S. 943 (1964) (cancer from cigarette smoke).
6
oSupra note 9.
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eighty dollars per unit. 1 If the cost of hepatitis insurance is paid solely
out of the price of blood, the price of blood may be doubled. Further-
more, if the price of blood became exorbitant, it may affect the decisions
of the attending physician. Although, theoretically, price should not affect
a physician's judgment, as a practical matter it does. Blood, formerly
given to speed recovery, may be withheld if the physician feels the price
of blood may have a crushing economic impact on the patient.
Although the above figures are not exact, they are instructive to show
that courts should carefully consider the economic impact of the imposition
of strict liability. It is noteworthy that in the Cunningham decision al-
though the court discussed concepts of charitable immunity at length, it
does not mention the economic impact of strict liability on the price of
blood.
Further arguments against strict liability can be made from examining
the policy of § 402A of the Restatement (Second) of Torts. Is blood
infected by hepatitis a "product in a defective condition unreasonably
dangerous" to the patient? In almost all cases blood is administered
to save lives; therefore, withholding blood may have serious consequences,
including death. The administration of infected blood may still save a
life even though it causes subsequent hospitalization for hepatitis. Under
these circumstances administration of blood in such a defective condition is
not unreasonably dangerous.
The comment (k) exception concerning unavoidably unsafe products
would also seem to support this position. The Cunningham court distin-
guished this comment by saying it applied only to pure products and not
impure blood. But the court did not take note of the following language
in comment (k):
It is also true in particular of many new or experimental drugs as to which,
because of the lack of time or opportunity for sufficient medical experience,
there can be no assurance of safety, or perhaps even purity of ingredients,
but such experience as there is justifies the marketing and use of the drug
notwithstanding a medically recognizable risk.02
This language indicates that the comment (k) exception was to include
not only unsafe pure drugs such as rabies vaccine, but also unsafe and
impure drugs such as virus infected blood. So the policy of comment (k)
would seem to include blood even though the Cunningham court chose to
distinguish it.
Strict liability in tort as described in § 402A is a flexible and use-
81 14 Am. JuM, Proof of Facts, 149-151 (1961). This is assuming one pint of blood per
transfusion. Even assuming one transfusion contains three pints of blood the effect on the price
of blood would still be considerable. Empirical proof in this area is difficult to obtain. Some
figures place the incidence of serum hepatitis at an annual rate of only 8,000 patients. In this
case the rise in price would be ten dollars. This is still more of an economic impact than the
few cents usually contemplated by the imposition of strict liability.02 RlsTATEMNT OF TORTS (SEcOND) § 402 A, comment k (1966) (emphasis supplied).
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ful legal tool. In recent years it has become an effectual and popular
cause of action. However, the concept of strict liability in tort needs fur-
ther consideration and refinements particularly in light of the economic
impact of decisions imposing such liability. The Cunningham approach to
the language of § 402A would seem to be too mechanical and perhaps no
better than the sales-service approach of Perlmutter.
Thus in the case of undetectible impurities in beneficial drugs the
weight of the evidence is against the imposition of strict liability if: (1)
the impurity is completely undetectible, (2) the presence of the impurity
is not preventible by screening donors, (3) the percentage of the oc-
currence is so high that the cost cannot be effectively distributed at a mod-
erate cost.
A possible alternative to strict liability would involve hospitalization
insurance. Collateral benefits such as hospitalization insurance and sick
pay usually prevent victims of serum hepatitis from being economically
destroyed. One may argue that recovery in many instances by serum hepa-
titis patients would be a windfall. Of course, American tort law has a
"no collateral benefits" rule whereby the amount of collateral benefits
does not mitigate the amount of recovery." But if blood becomes finan-
cially prohibitive, and the cost of strict liability is weighed against the harm
to patients, then it is arguable that the "no collateral benefits" rule should
be abolished, and in its stead permit recovery only in the excess of collateral
benefits. If courts ultimately opt for imposing liability, then the abolition
of the no collateral benefits rule could serve as a middle ground to decrease
the amount of recovery and therefore decrease the resultant amount of
increase in the price of blood needed to pay for hepatitis insurance.
The law is often affected by advances in medical science. These blood
cases are no exceptions. Recent discoveries have raised the possibility that
within the next few years the virus of serum hepatitis may be readily de.
tectible in the blood of the donor. The National Institute of Health
recently announced the first governmental licensing of a test used to screen
hepatitis in the blood. The new test which is inexpensive and easily per-
formed is twenty-five to fifty percent effective in detecting hepatitis in-
fected blood. 4 If this test and other methods presently being explored
prove effective, the attack rate of two percent could be significantly
reduced. Additional reduction in the attack rate may be obtained by new
techniques in screening donors. If this were possible, the cost could then
be distributed among the users of blood with only a slight increase in the
cost on blood. Under such circumstances imposition of strict liability
63Maxwell, The Collateral Source Rule in the American Law of Damages, 46 MIN. L
REv. 669 (1962).
6 Wall St Jour., Mar. 2 ,1971 at 1, col. 1. This test indicates the presence of Australia anti.
gen, a substance linked with serum hepatitis. If the antigen is present in the blood there is a
high probability that the hepatitis virus is also present
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would be plausible. Furthermore, the imposition of liability may have a
deterrent effect in encouraging searches for further methods to reduce lia-
bility. If hospitals and others are held liable, then there may be encourage-
ment for more careful screening of donors.
Perhaps legal liability is not the answer. This area may be better
served by an insurance alternative. One suggestion would be to establish
some form of insurance whereby patients receiving blood and wishing to
insure against the risk of contracting serum hepatitis could easily do so.
But this approach would probably have to be initiated by the legislature.
Historically, legislatures have absolved hospitals from liability without at-
tempting to deal any further with the problem."
As new techniques are developed, serum hepatitis may eventually be
prevented. Hopefully, the development of a vaccine to immunize against
the disease will render these cases moot, but the considerations involved
such as warranties, strict liability and hospitals will continue to be relevant.
Alan Radnor
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